Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAS181 in Adult Subjects With Naturally Acquired Influenza
NCT01740063Phase 2Completed
- Sponsor
- Ansun Biopharma
- Start
- Nov 2012
- Primary completion
- Jan 2014
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of DAS181 in influenza, sponsored by Ansun Biopharma. Started Nov 2012; status: completed.
02
Drugs
DAS181
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01740063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01740063.